Osteonecrosis of the Jaw (ONJ) Case Registry
The purpose of the ONJ case registry is to describe the natural history of
positively-adjudicated ONJ in subjects with cancer with an observation period of 5 years.
Most of these subjects are expected to have received bone antiresorptive agents such as
bisphosphonates or denosumab together with cancer-specific therapies (eg, chemotherapy,
steroids, or anti-angiogenics). It is also possible that the registry will include subjects
with cancer who developed ONJ without exposure to any antiresorptive therapy.
Observational
Observational Model: Case-Only, Time Perspective: Prospective
Resolution rate and time to ONJ resolution
5 years
No
MD
Study Director
Amgen
Belgium: Federal Agency for Medicinal Products and Health Products
20101102
NCT01666106
October 2012
March 2021
Name | Location |
---|---|
Research Site | Anaheim, California |
Research Site | Boulder, Colorado |
Research Site | Washington, District of Columbia |
Research Site | Boca Raton, Florida |
Research Site | Albany, Georgia |
Research Site | Arlington Heights, Illinois |
Research Site | Ames, Iowa |
Research Site | Baltimore, Maryland |
Research Site | Grand Island, Nebraska |
Research Site | Albany, New York |
Research Site | Asheville, North Carolina |
Research Site | Chattanooga, Tennessee |
Research Site | Abilene, Texas |